These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2871103)
1. Activity of teicoplanin in localized experimental infections in rats. Arioli V; Berti M; Candiani G J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103 [TBL] [Abstract][Full Text] [Related]
2. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Galetto DW; Boscia JA; Kobasa WD; Kaye D J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303 [TBL] [Abstract][Full Text] [Related]
3. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Chambers HF; Sande MA Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747 [TBL] [Abstract][Full Text] [Related]
4. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus]. Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757 [TBL] [Abstract][Full Text] [Related]
6. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections. Klastersky J; Van der Auwera P J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212 [TBL] [Abstract][Full Text] [Related]
7. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy. Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Sullam PM; Täuber MG; Hackbarth CJ; Sande MA Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344 [TBL] [Abstract][Full Text] [Related]
9. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135 [TBL] [Abstract][Full Text] [Related]
10. Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model. Tuazon CU; Washburn D J Antimicrob Chemother; 1987 Aug; 20(2):233-7. PubMed ID: 2959643 [TBL] [Abstract][Full Text] [Related]
11. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842 [TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Fernandez-Guerrero M; Rouse M; Henry N; Wilson W Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989 [TBL] [Abstract][Full Text] [Related]
13. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. Shibl AM; Ishag AH; Durgham SM APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301 [TBL] [Abstract][Full Text] [Related]
14. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. Chambers HF; Kartalija M; Sande M J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757 [TBL] [Abstract][Full Text] [Related]
16. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526 [TBL] [Abstract][Full Text] [Related]
17. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis. Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890 [TBL] [Abstract][Full Text] [Related]
18. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. McGrath BJ; Kang SL; Kaatz GW; Rybak MJ Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015 [TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome. Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248 [TBL] [Abstract][Full Text] [Related]
20. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]